Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
about
TWEAK and the progression of renal disease: clinical translationLupus nephritis: the evolving role of novel therapeuticsA Bioinformatics Resource for TWEAK-Fn14 Signaling PathwayThe pathogenesis, diagnosis and treatment of lupus nephritis.Systemic lupus erythematosus diagnostics in the 'omics' eraUrinary biomarkers in lupus nephritis.TWEAK enhances E-selectin and ICAM-1 expression, and may contribute to the development of cutaneous vasculitis.OX40/OX40L in systemic lupus erythematosus: association with disease activity and lupus nephritis.Colony-stimulating factor-1: a potential biomarker for lupus nephritis.TWEAK-Fn14 as a mediator of acute kidney injury.TWEAK/Fn14 system and crescent formation in IgA nephropathy.Dialogue: A blissful future for lupus nephritis: harnessing repeat kidney biopsies to identify meaningful biomarkers of disease.Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis.Biomarkers for kidney involvement in pediatric lupus.Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus.Lupus nephritis: an overview of recent findings.Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases.The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus NephritisInhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritisFn14-Fc suppresses germinal center formation and pathogenic B cells in a lupus mouse model via inhibition of the TWEAK/Fn14 Pathway.Urinary angiostatin--a novel putative marker of renal pathology chronicity in lupus nephritis.Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosusTumor Necrosis Factor-Like Weak Inducer of Apoptosis Accelerates the Progression of Renal Fibrosis in Lupus Nephritis by Activating SMAD and p38 MAPK in TGF-β1 Signaling PathwayBiomarkers in systemic lupus erythematosus: challenges and prospects for the future.The role of soluble tumor necrosis factor like weak inducer of apoptosis and interleukin-17A in the etiopathogenesis of celiac disease: A cross-sectional study.Biomarkers and updates on pediatrics lupus nephritis.A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis.Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?International validation of a urinary biomarker panel for identification of active lupus nephritis in children.Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.Biomarkers for lupus nephritis: a critical appraisal.Treatment of proliferative lupus nephritis: a slowly changing landscape.The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis.Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis.Urine biomarkers in juvenile-onset SLE nephritis.Role of TWEAK in lupus nephritis: a bench-to-bedside review.Diagnosis and treatment of lupus nephritis flares--an update.The TWEAK-Fn14 system as a potential drug target.Promising biomarkers for systemic lupus erythematosus.
P2860
Q26996775-97710F4B-B0DF-4AB6-9F22-00B9A5FF0DE9Q26998390-D91B7C0C-026E-497A-BE52-2939FD24FE91Q28729829-035BFF3A-4F00-48DB-824D-4EFD17E8FD95Q30596968-349BDC45-2EB6-47D2-A861-18D8E553D2ADQ33644106-74A0C9B1-2267-4065-A450-48A5026A7623Q34050022-F16C7F8D-F231-4DD0-9DF2-EC061981B62FQ34607114-2B4B3F0B-9BA3-4CA1-BDE0-FE6CE7BB15F0Q35006093-1AE006FA-E216-4A3E-A627-B7384E6D937FQ35027273-0282A6D3-7756-4AC4-B100-ED694806EB24Q35073736-49E1B643-2FB9-4038-ABAB-7625D31DAAB1Q35187418-9A9E0DDB-ACB6-41F1-845F-AD57F71BEEBFQ35280905-79B71FCF-2AC4-4C87-A24F-369FFF421439Q35550587-4DD9DAB6-95E4-4FAE-A216-85C2D4E0751EQ35810911-33B3D3E6-3186-40BD-8D54-27A3473733CBQ35830106-A4B60551-68D1-4264-AB0A-07BB86927468Q35867038-FEA7D94F-C384-421E-86B8-69FE319E28D5Q36031863-88B12AF5-781C-493A-9019-D64F16F5F267Q36299959-15289DEC-3355-4865-8DEA-ACDDAB196051Q36354235-5F7DD1AA-1654-4735-9399-E64D6C5C972CQ36820363-39249188-439F-4268-9468-AE0A3471F77EQ36832462-8EFFD2FC-0D93-453A-B9A2-FBA594F91209Q36902003-3D230024-4018-4AA9-B212-1892517570DFQ36903365-D57D88F2-1D43-42AA-B534-A0B92357D247Q37018721-B3398CAC-A337-4C58-9E39-0077C4240AFFQ37058781-132324A5-E488-40CD-B927-85B0B192AD4DQ37077884-FB53101F-09CE-4834-8D90-88CC17256A2EQ37167062-F870F61C-F185-4CA0-8869-552317B7E815Q37311370-81EBF439-E4BD-43A3-9C60-D2CC425345C8Q37415529-E3ED2449-E813-4AF3-9FBA-05330760EE50Q37547407-37A14F59-55B9-4D44-B694-E1930BCB7567Q37690660-17C1E1A6-8ED1-4A65-991A-D8B751B59EB4Q37736277-73DEC4DA-5E7B-4084-9544-E66040FC6DA2Q37822658-CBA2047D-E39D-4EE0-8B8E-2C81F7B938F6Q37849465-979F3E74-99C3-4C73-99EF-8FA2C672539FQ37980604-9F9DA24B-1C64-4D02-88F6-FD4F6E784CA1Q38010347-EEB0808B-81AF-4D0B-9323-FE610FB9C807Q38021183-5673E9C2-F0E4-43D6-AC9F-64460410A35DQ38059445-646D1EBA-4853-4B71-9AC1-876CF7B0C804Q38129961-6C634C6F-D0D5-41EC-A369-681F72C69B7FQ38149960-F8F284F3-D48A-4448-8EC4-60F17FAC2AF0
P2860
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
@en
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
@nl
type
label
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
@en
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
@nl
prefLabel
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
@en
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
@nl
P2093
P2860
P356
P1476
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
@en
P2093
Bernard Hojaili
Brad H Rovin
Chaim Putterman
Cynthia Aranow
Irene Blanco
Jennifer S Michaelson
Linda C Burkly
Meggan Mackay
Noa Schwartz
P2860
P2888
P356
10.1186/AR2816
P577
2009-09-28T00:00:00Z
P5875
P6179
1020733895